Bio-Thera Solutions Reports the Initiation of Combined P-I/P-III Study of BAT3306 (Biosimilar, Keytruda)
Shots: Bio-Thera Solutions has commenced the patients dosing under the combined P-...
Shots: Bio-Thera Solutions has commenced the patients dosing under the combined P-...
Shots: The US FDA and EMA have accepted the BLA & MAA of BAT2206 for treating...
Shots: The US FDA has granted approval to the company’s BLA of Epysqli (ecul...
Shots: Alvotech has reported data from the confirmatory P-III (
Shots: Kashiv BioSciences has signed an exclusive licensing agreement with Amneal...
Shots: The US FDA has approved Pyzchiva, a biosimilar of Stelara (ustekinumab), fo...
Incisive News in 3 Shots.